PharmacyFirst Plan

1 / 21
About This Presentation
Title:

PharmacyFirst Plan

Description:

Title: PharmacyFirst Plan Author: Ivan Solero Last modified by: Suzanne Tyler Document presentation format: On-screen Show Other titles: Arial Pro ... – PowerPoint PPT presentation

Number of Views:1
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: PharmacyFirst Plan


1
Patient Compliance, Adherence, and Persistence
Tim R. Garde Managing Partner The Star
Group May 20, 2008
2
//Definitions
  • Patient Compliance general term for the extent
    to which patients follow their physicians
    directions with medications
  • Adherence used to define appropriateness of
    use, typically calculated as a proportion of
    prescribed doses that are actually taken as
    prescribed (i.e., a fraction)
  • Persistence a measure of duration, in terms of
    days, months, or years
  • Patient Compliance, Adherence,
    and Persistence

3
//Target Audiences
  • Patientsimproving health and quality of life
  • Caregivers
  • Health Care Providers Physicians and
    Pharmacists
  • Payors
  • Healthcare System
  • Patient Compliance, Adherence,
    and Persistence

4
//The Facts
  • 60 of physician visits result in a pharmacy
    prescription
  • 50 of patients fail to have initial
    prescriptions filled
  • 20 of patients comply
  • 30 of patients fail to refill their
    prescriptions
  • 30-50 decline after 1st or 2nd refill
  • Patient Compliance, Adherence,
    and Persistence
  • Various Commercially Available Sources, 2007-2008

5
//The Facts
  • Low adherence can cost an extra 2,000 a year per
    patient in extra physician visits alone
  • 177 billion in medical bills and lost
    productivity due t poor medication adherence
  • The poor are the least compliantthe healthiest
    are the most compliant
  • Patient
    Compliance, Adherence, and Persistence
  • Various Commercially Available Sources,
    2007-2008

6
//Rates and Possible Consequencesof
Non-Adherence
  • Condition Non-Adherence Rate Consequence
  • Epilepsy 30-50 Relapse
  • Arthritis 55-70 Pain
  • Hypertension 40 Hospitalization
  • Diabetes 40-50 Loss of Control
  • Asthma 20 In-patient Visits
  • Alcoholism 48-56 Relapse
  • Anticoagulants 30 Bleeding
  • Estrogen RT 57 Osteoporosis
  • Patient Compliance,
    Adherence, and Persistence
  • Source GlaxoSmithKline 2008

7
//Why Patients Do Not Comply
  • Forget
  • Do not understand or misinterpret instructions
  • Obstacles (i.e., difficulty in swallowing,
    opening bottle)
  • Adverse side effects / lack of understanding or
    confidence in drug safety
  • Cost / lack of insurance coverage
  • Patient Compliance,
    Adherence, and Persistence
  • Source Alliance Healthcare Information, Inc.,
    2008

8
//Why Patients Do Not Comply
  • Feel better
  • Deny illness
  • Do not believe drug will help
  • Do not care about getting better
  • Worry about becoming resistant to the drug or
    think the dug is not working because they do not
    feel different
  • Patient Compliance,
    Adherence, and Persistence
  • Source Alliance Healthcare Information, Inc.,
    2008

9
//Critical Success Factors ToOvercoming
Non-Adherence
  • Patient education is key
  • gt it is about changing behavior
  • gt the more educated patients are about a
    particular disease, the more wiling they are
    to adapt their behavior and motivation
  • Pharmaceutical company call center nurses
  • gt treating patients like people!
  • Better and more accurate databases
  • gt allow pharmaceutical companies to analyze
    whats been prescribed and compare to what is
    already filled
  • Patient Compliance, Adherence,
    and Persistence

10
// Critical Success Factors ToOvercoming
Non-Adherence
  • Improve the communication chain among physicians,
    pharmacists, payors
  • gt minimize the misunderstandings,
    inconsistencies
  • gt understand the barriers and motivators
  • gt set reasonable expectations
  • Leverage the pharmacist as a highly influential
    source of contact
  • gt relevance why it is important to stay on
    therapy
  • gt repetition takes 2 to 5 messages or
    communications to change or modify behavior
  • gt comfort level patients are comfortable with
    and trust their pharmacists
  • Patient Compliance, Adherence,
    and Persistence

11
//Patient Relationship Management
  • At the point of pharmacy, patients are thinking
    about their health
  • gt pharmacist can answer questions
  • Education materials need to focus on questions
    patients should ask a physician or pharmacist
  • gt critical for patient retention
  • Need to improve the one size fits all strategy
    within a specific indication
  • gt Set expectations for specific disease state
    and patient populations (Alzheimers
    Disease)
  • Patient Compliance, Adherence,
    and Persistence

12
//
//Patient Relationship Management
  • Must do a better job of aligning risk-reward
    scenarios
  • gt patients need an accurate understanding of the
    risks and benefits of the mediation or
    therapy
  • gt physicians, pharmacists, and payers need to
    communicate these facts
  • gt Here is the risk if you do not take it, here
    is the reward if you do
  • Need to better understand why patients do not
    comply and why they do complyit is about
    behavior
  • gt the reasons why a patient chooses not to take
    his/her medication anymore may be different
    than the reasons why a patient chooses to
    take half the dose or than the reasons why
    they just forget
  • Patient Compliance, Adherence,
    and Persistence

13
  • The motivation for taking prescriptions is
    personal
  • Patient Compliance, Adherence,
    and Persistence

14
//What Motivates Patients To Be
Compliant.Changing Behavior
  • Counseling by physicians and pharmacists
  • Pill boxes
  • Email alerts / electronic reminders
  • Alarm devices
  • Phone calls
  • Patient Compliance, Adherence,
    and Persistence
  • Sources The Star Group Medical Monitor 2007,
    Available Data

15
//What Motivates Patients To Be
Compliant.Changing Behavior
  • Web sites / SEO
  • Discount coupons
  • Educational materials
  • Personal health records / online diaries
  • Patient Compliance, Adherence,
    and Persistence
  • Sources The Star Group Medical Monitor 2007,
    Available Data

16
//Measuring Success
  • Actual change in prescription volume
  • Need to consider integrated programs that work
    together
  • Utilize surveys with all audiences test vs.
    control groups
  • Use retail pharmacy and DTC communications
  • Patient Compliance, Adherence,
    and Persistence

17
//Measuring Success
  • Utilize data from patient advocacy groups, public
    and private payors
  • Physician time is limited leverage the
    pharmacist
  • Give the physician a reason to address adherence
    (i.e., quality performance criteria)
  • Patient starter kits, samplesability to capture
    names
  • Funding.spend wisely
  • Patient Compliance, Adherence,
    and Persistence

18
//Measuring Success
  • Utilize these multiple vehicles supported by
    pharmaceutical companies and payers
  • gt Letters
  • gt Newslettersincluding from 3rd parties
  • gt DVDs
  • gt Email
  • gt Websites / Social networking / Blogs
  • gt Patient assistance programs
  • gt Onsite physician and pharmacy consulting
  • Patient Compliance,
    Adherence, and Persistence

19
//Measuring Success
  • 2-10 improvements in compliance are good do
    not expect 50 range
  • 1 increase in patient loyalty 10 cost
    reduction
  • The success probability of selling to a new
    patient is only 5-20, while the success
    probability of selling to an existing patient is
    60-70
  • Patient
    Compliance, Adherence, and Persistence
  • Sources Bain Co., 2008, Marketing Metrics,
    2008

20
//What Must Pharmaceutical Companies Do
  • Evaluate underlying specific causes for patient
    non-compliance with their brands to guide
    effective program implementation
  • Address barriers to successful program
    implementation with all audiences patients,
    physicians, pharmacists, payers
  • Understand the return on investment for specific
    activitiesbe willing to analyze program results
    and refine as necessary
  • Patient Compliance, Adherence,
    and Persistence
  • Source Pharmaceutical Executive, March 2008

21
  • Questions?
  • Patient
    Compliance, Adherence, and Persistence
Write a Comment
User Comments (0)